IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced the appointment of D. Keith Grossman to its board of directors.
“Keith is a recognized leader in our industry, and brings a wealth of experience and judgment in guiding innovative device companies through aggressive growth, strategic change, and value creation. I’m confident he will make vital contributions to TherOx as we continue to advance toward our goal of bringing SuperSaturated Oxygen Therapy to the U.S. market,” said Kevin T. Larkin, president and chief executive officer of TherOx.
